dalteparin has been researched along with Uterine Diseases in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Uterine Diseases: Pathological processes involving any part of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maciejczyk-Pencuła, M | 1 |
| Polak, G | 1 |
| Kotarski, J | 1 |
1 trial available for dalteparin and Uterine Diseases
| Article | Year |
|---|---|
Serum acute phase protein concentrations after hysterectomy with and without low-molecular-weight heparin thrombosis prophylaxis.
Topics: Acute-Phase Proteins; Biomarkers; C-Reactive Protein; Dose-Response Relationship, Drug; Drug Adminis | 2005 |